Table 1.
Sample characteristics and subgroups of lectin microarray cohort.
| PBC (n = 99) | DC (n = 70) | HC (n = 38) | ||||||
|---|---|---|---|---|---|---|---|---|
| AMA-M2+ Group A | AMA-M2– Group B | sp100+ Group C | gp210+ Group D | ACA+ Group E | AIH | PSS | ||
| n | 20 | 20 | 19 | 20 | 20 | 30 | 40 | 38 |
| Male/Female | 1/9 | 3/17 | 1/18 | 1/19 | 1/19 | 1/14 | 1/9 | 3/35 |
| Age (Mean ± SD)(year) | 52.40 ± 10.62 | 53.35 ± 11.14 | 56.89 ± 10.72 | 50.70 ± 7.97 | 54.55 ± 12.04 | 44.86 ± 19.28 | 48.52 ± 9.73 | 45.60 ± 7.64 |
| AMA-M2 autoantibody | + | – | + | + | + | NA | NA | NA |
| Anti-sp100 autoantibody | – | – | + | – | – | NA | NA | NA |
| anti-gp210 autoantibody | – | – | – | + | – | NA | NA | NA |
| ACA autoantibody | – | – | – | – | + | NA | NA | NA |
PBC, primary biliary cholangitis; DC, disease control; AIH, autoimmune hepatitis; PSS, primary Sjögren’s syndrome; HC, healthy control; AMA-M2, antimitochondrial antibody M2; gp210, anti-glycoprotein-210 antibody; sp100, sp100 nuclear antigen; ACA, anti-centromere antibody.